Welcome to the CEO Roundtable on Cancer Web Site

The mission of the CEO Roundtable on Cancer is to make continual progress toward the elimination of cancer as a personal disease and public health problem. Members of the CEO Roundtable collaboratively work to develop and implement initiatives that reduce the risk of cancer, enable early diagnosis, facilitate better access to best-available treatments, and hasten the discovery of novel and more effective diagnostic tools and anti-cancer therapies.



The Gold Standard is a workplace-based program that focuses on lowering the risk of cancer, detecting it early when outcomes are more likely to be favorable, and ensuring access to quality care.  Visit the Gold Standard web site for more information.



The Life Sciences Consortium (LSC) brings together oncology pharmaceutical/biotechnology companies who work to remove roadblocks and find new ways to accelerate discovery and development of new therapies for all cancer patients. Visit the LSC web site for more information.
February 12 2010
The CEO Roundtable on Cancer Salutes Duke Men’s Basketball Head Coach Mike Krzyzewski On His 1000th Game

"Coach K," Honorary CEO Roundtable on Cancer Member, Mike Krzyzewski, leads the Duke Blue Devils - and the fight against cancer in the workplace.
photo credit: Lance King
Read More
January 29 2010
Judy O’Hagan named CEO Cancer Gold Standard Task Force Chair
CARY, NC (January 28, 2010) – Judy O’Hagan has been named Chairman of the CEO Cancer Gold Standard Task Force and will help lead a nationwide, workplace-based effort to encourage more companies to reduce the cancer risk for employees and their families through screenings, early detection, and healthy changes in lifestyle.
Read More
January 21 2010
The CEO Roundtable on Cancer Salutes SAS and Meridian Health
The CEO Roundtable on Cancer, the nonprofit organization of cancer-fighting CEOs who created the CEO Cancer Gold Standard, salutes SAS Institute for being ranked No.1 on FORTUNE magazine’s annual “100 Best Companies to Work For” list.
Read More